Analyst firms · Robert W. Baird · DOCS
Robert W. Baird DOCS price target and rating history
Doximity Inc. (DOCS) · Technology
Robert W. Baird rates Doximity Inc. (DOCS) Neutral with a $18 price target, as of its latest action on May 14, 2026. It has published 3 rating actions on DOCS since November 2021, including 0 upgrades and 1 downgrade. Across 12 firms with a DOCS price target in the last 12 months, the median target is $27. Robert W. Baird's $18 is 33% below that.
- Current rating
- Neutral
- Price target
- $18
- Median target, all firms
- $27
- Actions on DOCS
- 3
Robert W. Baird price target on DOCS
Every Robert W. Baird rating on DOCS
- May 14, 2026
- Nov 17, 2021
- Nov 17, 2021
How other firms rate DOCS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wells Fargo | Underweight | $18 | Aug 10, 2026 |
| BofA Securities | Underperform | $20 | Jun 29, 2026 |
| Barclays | Equal Weight | $20 | May 15, 2026 |
| KeyBanc Capital Markets | Sector Weight | May 14, 2026 | |
| Robert W. Baird | Neutral | $18 | May 14, 2026 |
| BTIG | Neutral | May 14, 2026 | |
| Jefferies | Hold | $19 | May 14, 2026 |
| Truist Securities | Hold | $29 | Apr 20, 2026 |
| Evercore ISI | In-line | $25 | Apr 8, 2026 |
| Canaccord Genuity | Buy | $34 | Feb 9, 2026 |
| RBC Capital Markets | Outperform | $59 | Jan 9, 2026 |
| Morgan Stanley | Overweight | $65 | Dec 15, 2025 |
| Raymond James | Strong Buy | $65 | Nov 21, 2025 |
| BMO Capital Markets | Market Perform | $55 | Nov 13, 2025 |
Questions about Robert W. Baird and DOCS
- What is Robert W. Baird's price target for DOCS?
- Robert W. Baird's latest stated price target for Doximity Inc. (DOCS) is $18, from its action on May 14, 2026.
- What is Robert W. Baird's rating on DOCS?
- Robert W. Baird rates DOCS Neutral, a neutral rating, as of May 14, 2026.
- When did Robert W. Baird last change its view on DOCS?
- On May 14, 2026, Robert W. Baird downgrades to Neutral from Outperform, price target $18.
- How does Robert W. Baird's DOCS target compare with other analysts?
- Across 12 firms with a DOCS price target in the last 12 months, the median target is $27. Robert W. Baird's $18 is 33% below that.
More DOCS rating histories
- Wells Fargo7
- BofA Securities6
- Barclays4
- KeyBanc Capital Markets3
- BTIG3
- Jefferies3
- Truist Securities3
- Evercore ISI3
- Canaccord Genuity4
- Morgan Stanley8
- Raymond James5
- Goldman Sachs6
- Piper Sandler4
- Leerink Partners4
- Needham6
- J.P. Morgan4
- Guggenheim3
All Robert W. Baird ratingsDOCS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.